FI953575A - Vattenhaltig medicinsk sammansättning, som har reversibel varmhärdande stelningsegenskap - Google Patents

Vattenhaltig medicinsk sammansättning, som har reversibel varmhärdande stelningsegenskap Download PDF

Info

Publication number
FI953575A
FI953575A FI953575A FI953575A FI953575A FI 953575 A FI953575 A FI 953575A FI 953575 A FI953575 A FI 953575A FI 953575 A FI953575 A FI 953575A FI 953575 A FI953575 A FI 953575A
Authority
FI
Finland
Prior art keywords
medical composition
reversible hot
solidifying properties
aqueous medical
application
Prior art date
Application number
FI953575A
Other languages
English (en)
Finnish (fi)
Other versions
FI953575A0 (sv
FI112778B (sv
Inventor
Masanobu Takeuchi
Hiroe Suzuki
Toshie Takahashi
Hiroki Maruyama
Miyako Sasaki
Keiko Naitou
Touru Oguma
Masayoshi Goto
Original Assignee
Wakamoto Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wakamoto Pharma Co Ltd filed Critical Wakamoto Pharma Co Ltd
Publication of FI953575A0 publication Critical patent/FI953575A0/sv
Publication of FI953575A publication Critical patent/FI953575A/sv
Application granted granted Critical
Publication of FI112778B publication Critical patent/FI112778B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Thermotherapy And Cooling Therapy Devices (AREA)
FI953575A 1993-04-16 1995-07-26 Förfarande för framställning av en vattenhaltig medicinsk sammansättning, som har reversibel varmhärdande stelningsegenskap FI112778B (sv)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP11234593 1993-04-16
JP11234593 1993-04-16
PCT/JP1993/001636 WO1994023750A1 (en) 1993-04-16 1993-11-10 Reversible, thermally gelling water-base medicinal composition
JP9301636 1993-11-10

Publications (3)

Publication Number Publication Date
FI953575A0 FI953575A0 (sv) 1995-07-26
FI953575A true FI953575A (sv) 1995-07-26
FI112778B FI112778B (sv) 2004-01-15

Family

ID=14584369

Family Applications (1)

Application Number Title Priority Date Filing Date
FI953575A FI112778B (sv) 1993-04-16 1995-07-26 Förfarande för framställning av en vattenhaltig medicinsk sammansättning, som har reversibel varmhärdande stelningsegenskap

Country Status (17)

Country Link
US (1) US5624962A (sv)
EP (1) EP0694310B1 (sv)
KR (1) KR0162025B1 (sv)
CN (1) CN1048393C (sv)
AT (1) ATE189772T1 (sv)
AU (1) AU668447B2 (sv)
CA (1) CA2153234C (sv)
DE (1) DE69327878T2 (sv)
DK (1) DK0694310T3 (sv)
ES (1) ES2141775T3 (sv)
FI (1) FI112778B (sv)
HK (1) HK1017805A1 (sv)
HU (1) HU220864B1 (sv)
IL (1) IL107626A (sv)
NO (1) NO311635B1 (sv)
RU (1) RU2108112C1 (sv)
WO (1) WO1994023750A1 (sv)

Families Citing this family (77)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6436425B1 (en) 1988-11-16 2002-08-20 Mdv Technologies, Inc. Method and non-gelling composition for inhibiting post-surgical adhesions
US5346703A (en) 1990-08-07 1994-09-13 Mediventures, Inc. Body cavity drug delivery with thermo-irreversible polyoxyalkylene and ionic polysaccharide gels
US5318780A (en) * 1991-10-30 1994-06-07 Mediventures Inc. Medical uses of in situ formed gels
KR100356882B1 (ko) * 1994-03-28 2003-03-10 더 트러스티스 오브 컬럼비아 유니버시티 인 더 시티 오브 뉴욕 글루콘산아연 겔 조성물
WO1996011672A1 (fr) * 1994-10-13 1996-04-25 Wakamoto Pharmaceutical Co., Ltd. Preparation lyophilisee permettant d'obtenir une composition pharmaceutique a base d'eau se transformant de maniere reversible en gel sous l'effet de la chaleur
DE19511322C2 (de) 1995-03-28 1999-09-02 Mann Gerhard Chem Pharm Fab Sterile Augengele mit einem Gehalt an mittelkettigen Triglyceriden und Verfahren zu deren Herstellung
US5843470A (en) 1995-10-06 1998-12-01 Mdv Technologies, Inc. Method and composition for inhibiting post-surgical adhesions
CA2232855C (en) * 1997-04-10 2007-10-09 Roche Consumer Health (Worldwide) Sa Pharmaceutical formulation
CA2289618A1 (en) * 1997-05-14 1998-11-19 Shin-Ichi Yasueda Aqueous suspension preparations with excellent redispersibility
AU753206B2 (en) * 1997-12-23 2002-10-10 Alliance Pharmaceutical Corporation Methods and compositions for the delivery of pharmaceutical agents and/or the prevention of adhesions
US6197347B1 (en) 1998-06-29 2001-03-06 Andrx Pharmaceuticals, Inc. Oral dosage for the controlled release of analgesic
ES2155027B1 (es) * 1999-05-24 2001-12-01 Univ Pais Vasco Geles para propositos multiples, reversibles y degradables.
AU769853B2 (en) * 1999-06-11 2004-02-05 Atossa Genetics, Inc. Gel composition for filing a breast milk duct prior to surgical excision of the duct or other breast tissue
US20020061281A1 (en) * 1999-07-06 2002-05-23 Osbakken Robert S. Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis
US6576224B1 (en) * 1999-07-06 2003-06-10 Sinuspharma, Inc. Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis
JP2001158750A (ja) * 1999-12-02 2001-06-12 Lion Corp 眼科用組成物及び抗アレルギー薬の持続性向上方法
JP3450805B2 (ja) * 2000-08-08 2003-09-29 わかもと製薬株式会社 水性医薬組成物
US7420030B2 (en) 2000-09-08 2008-09-02 The Board Of Regents Of The University Of Texas System Aminopeptidase A (APA) targeting peptides for the treatment of cancer
CA2423354C (en) * 2000-09-20 2009-12-15 Lee Shahinian Jr. Self-preserved nasal, inhalable, and topical ophthalmic preparations and medications
JP4820024B2 (ja) * 2001-01-10 2011-11-24 昭和薬品化工株式会社 局所麻酔用組成物
CA2454357A1 (en) * 2001-07-18 2003-01-30 Wadih Arap An anti-angiogenic state in mice and humans with retinal photoreceptor cell degeneration
US20040048243A1 (en) * 2001-09-07 2004-03-11 Wadih Arap Methods and compositions for in vitro targeting
US6846846B2 (en) * 2001-10-23 2005-01-25 The Trustees Of Columbia University In The City Of New York Gentle-acting skin disinfectants
US7879365B2 (en) 2002-02-07 2011-02-01 The Trustees Of Columbia University In The City Of New York Zinc salt compositions for the prevention of dermal and mucosal irritation
AU2003216213B2 (en) 2002-02-07 2008-10-02 The Trustees Of Columbia University In The City Of New York Zinc salt compositions for the prevention of mucosal irritation from spermicides and microbicides
US7745425B2 (en) 2002-02-07 2010-06-29 The Trustees Of Columbia University In The City Of New York Non-irritating compositions containing zinc salts
AU2003211238A1 (en) * 2002-02-22 2003-09-09 Santen Pharmaceutical Co., Ltd. Drug delivery system for the subconjunctival administration of fine grains
US20030211173A1 (en) * 2002-05-08 2003-11-13 Veach Tom C. Lubrication composition
JPWO2004026953A1 (ja) * 2002-09-18 2006-01-19 わかもと製薬株式会社 透明な可逆性熱ゲル化水性組成物
US7220431B2 (en) 2002-11-27 2007-05-22 Regents Of The University Of Minnesota Methods and compositions for applying pharmacologic agents to the ear
JP2004196787A (ja) * 2002-12-04 2004-07-15 Santen Pharmaceut Co Ltd 結膜下デポによるドラッグデリバリーシステム
AU2003289011A1 (en) * 2002-12-10 2004-06-30 Showa Yakuhin Kako Co., Ltd. Composition for topical anesthesia
US20050085446A1 (en) * 2003-04-14 2005-04-21 Babu M.K. M. Fluoroquinolone formulations and methods of making and using the same
JP4669960B2 (ja) * 2003-06-03 2011-04-13 株式会社 メドレックス 局所麻酔薬を含有する口中用または咽頭部用製剤
MXPA06000543A (es) * 2003-07-17 2006-03-30 Univ Columbia Composiciones antimicrobianas que contienen combinaciones sinergicas de compuestos de amonio cuaternario y aceites esenciales y/o constituyentes de estos.
EP1666025A4 (en) * 2003-08-20 2011-08-31 Santen Pharmaceutical Co Ltd DRUG DELIVERY SYSTEM FOR THE SUBTENOIN DELIVERY OF FINE GRAINS
FR2860718B1 (fr) * 2003-10-09 2006-02-24 Jean Pascal Conduzorgues Nouvelle formulation et ses applications dans le domaines cosmetiques ou pharmaceutiques
JP2007517806A (ja) * 2004-01-15 2007-07-05 オーラル バイオサイエンス ピーティーワイ． リミテッド 口腔用麻酔ゲル
US7658947B2 (en) * 2004-06-25 2010-02-09 Kimberly-Clark Worldwide, Inc. Thermo-gelling composition
JP2007277095A (ja) * 2004-07-02 2007-10-25 Wakamoto Pharmaceut Co Ltd アジスロマイシン含有可逆性熱ゲル化水性組成物
US7459416B2 (en) * 2004-07-12 2008-12-02 Panasonic Corporation Fluid bearing unit and spindle motor using the same
TW200716200A (en) 2005-03-10 2007-05-01 3M Innovative Properties Co Methods of reducing microbial contamination
JP4979258B2 (ja) * 2005-04-08 2012-07-18 ロート製薬株式会社 アシタザノラスト含有水性組成物
CN100463668C (zh) * 2005-05-09 2009-02-25 凌沛学 可逆性热凝胶化水性药物组合物
CN100430069C (zh) * 2005-07-28 2008-11-05 凌沛学 一种中药及其复方的可逆性热凝胶化水性药物组合物
JP5011118B2 (ja) 2005-10-17 2012-08-29 興和株式会社 インドメタシンを含有する外用液剤
EA008737B1 (ru) * 2005-12-07 2007-08-31 Леонид Андреевич Кожемякин Средство для профилактики и лечения конъюнктивитов и кератитов различной этиологии (варианты), способ его применения
US7759327B2 (en) 2006-01-06 2010-07-20 The Trustees Of Columbia University In The City Of New York Compositions containing zinc salts for coating medical articles
US20070249546A1 (en) * 2006-04-22 2007-10-25 Sawaya Assad S Ophthalmic and related aqueous solutions containing antifungal agents, uses therefor and methods for preparing them
US20080108674A1 (en) * 2006-05-01 2008-05-08 Enturia, Inc. Cationic antiseptic and dye formulation
US20070253909A1 (en) * 2006-05-01 2007-11-01 Medi-Flex, Inc. Aqueous Antiseptic Solution and Compatible Cationic Dye for Staining Skin
US20070254854A1 (en) * 2006-05-01 2007-11-01 Medi-Flex, Inc. Aqueous Antiseptic Solution and Compatible Anionic Dye for Staining Skin
TW200808375A (en) * 2006-05-12 2008-02-16 Otsuka Pharma Co Ltd Hydrogel suspension and manufacturing process thereof
EA014780B1 (ru) * 2007-01-05 2011-02-28 Промед Экспортс Пвт. Лтд. Офтальмическая композиция
DE102007002073A1 (de) * 2007-01-09 2008-07-10 Matthias Habenicht Mittel zur Pflege und antimikrobiellen Behandlung der Haut
JP5340149B2 (ja) * 2007-06-26 2013-11-13 わかもと製薬株式会社 水性組成物
ES2511840T3 (es) * 2007-08-29 2014-10-23 Wakamoto Pharmaceutical Co., Ltd. Composición farmacéutica acuosa que contiene latanoprost
WO2009074853A2 (en) * 2007-12-10 2009-06-18 Promed Research Centre Ophthalmic composition comprising phenylephrine
JP5551685B2 (ja) * 2008-05-14 2014-07-16 オトノミ―，インク． 制御放出型コルチコステロイド組成物、および耳の疾患を処置する方法
US10517839B2 (en) * 2008-06-09 2019-12-31 Cornell University Mast cell inhibition in diseases of the retina and vitreous
TW201023912A (en) * 2008-12-05 2010-07-01 Alcon Res Ltd Pharmaceutical suspension
WO2010101989A1 (en) * 2009-03-03 2010-09-10 Alcon Research, Ltd. PHARMACEUTICAL COMPOSITION FOR DELIVERY OF RECEPTOR TYROSINE KINASE INHIBITING (RTKi) COMPOUNDS TO THE EYE
MX2011008731A (es) * 2009-03-03 2011-09-29 Alcon Res Ltd Composicion farmaceutica para el suministro de compuestos inhibidores de la tirosina cinasa receptora (rtki) para los ojos.
EP2403342A4 (en) * 2009-03-03 2013-06-05 Alcon Res Ltd PHARMACEUTICAL COMPOSITION FOR IL-ADMINISTRATION OF TYROSINE KINASE RECEPTOR INHIBITING COMPOUNDS (RTKI)
WO2010135731A1 (en) * 2009-05-22 2010-11-25 Kaufman Herbert E Preparations and methods for ameliorating or reducing presbyopia
US8299079B2 (en) 2009-05-22 2012-10-30 Kaufman Herbert E Preparations and methods for ameliorating or reducing presbyopia
EP2609933A4 (en) 2010-08-27 2014-04-09 Wakamoto Pharma Co Ltd AQUEOUS COMPOSITION FOR ADMINISTRATION
TWI544922B (zh) 2011-05-19 2016-08-11 愛爾康研究有限公司 高濃度歐羅派特錠（ｏｌｏｐａｔａｄｉｎｅ）眼用組成物
WO2013169458A1 (en) * 2012-05-11 2013-11-14 Bausch & Lomb Incorporated Pharmaceutical compositions and methods for treating, controlling, ameliorating, or reversing conditions of dry eye
RU2485939C1 (ru) * 2012-06-19 2013-06-27 Станислав Анатольевич Кедик Офтальмологический препарат в виде глазных капель, содержащий дисульфирам и таурин
US10507245B2 (en) * 2012-07-19 2019-12-17 Luis Felipe Vejarano Restrepo Ophthalmic formulation and method for ameliorating presbyopia
RU2517033C1 (ru) * 2013-03-05 2014-05-27 федеральное государственное бюджетное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова" Министерства здравоохранения Российской Федерации Композиция для комплексного лечения больных с первичной открытоугольной глаукомой и заболеваниями глазной поверхности
CN103239390B (zh) * 2013-05-15 2014-08-06 中国人民解放军第三军医大学第二附属医院 托吡卡胺眼用温度敏感原位凝胶及其制备方法
RU2016122224A (ru) * 2013-12-20 2017-12-11 Дзе Проктер Энд Гэмбл Компани Стабильное жидкое лекарственное средство, содержащее дифенгидрамин
JP6714247B2 (ja) * 2017-10-06 2020-06-24 有限会社ジーエヌコーポレーション 尿道狭窄治療剤および尿道狭窄治療方法
JP7368799B2 (ja) * 2018-05-29 2023-10-25 学校法人 神野学園 外用組成物
AU2019386968B2 (en) * 2018-11-26 2022-12-22 Aiviva Biopharma, Inc. Pharmaceutical biodissolvable gels for drug delivery

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3311577A (en) * 1965-03-29 1967-03-28 Burton Parsons Chemicals Inc Underwater contact lens solution
US4188373A (en) * 1976-02-26 1980-02-12 Cooper Laboratories, Inc. Clear, water-miscible, liquid pharmaceutical vehicles and compositions which gel at body temperature for drug delivery to mucous membranes
US4100271A (en) * 1976-02-26 1978-07-11 Cooper Laboratories, Inc. Clear, water-miscible, liquid pharmaceutical vehicles and compositions which gel at body temperature for drug delivery to mucous membranes
DE2714065A1 (de) * 1977-03-30 1978-10-12 Boehringer Mannheim Gmbh Instillationszubereitung
US4474753A (en) * 1983-05-16 1984-10-02 Merck & Co., Inc. Topical drug delivery system utilizing thermosetting gels
US4474752A (en) * 1983-05-16 1984-10-02 Merck & Co., Inc. Drug delivery system utilizing thermosetting gels
US4478822A (en) * 1983-05-16 1984-10-23 Merck & Co., Inc. Drug delivery system utilizing thermosetting gels
US4474751A (en) * 1983-05-16 1984-10-02 Merck & Co., Inc. Ophthalmic drug delivery system utilizing thermosetting gels
FR2588189B1 (fr) * 1985-10-03 1988-12-02 Merck Sharp & Dohme Composition pharmaceutique de type a transition de phase liquide-gel
GB2203039B (en) * 1987-03-02 1990-10-24 American Cyanamid Co Stable ophthalmic preparations containing acetazolamide
US5252318A (en) * 1990-06-15 1993-10-12 Allergan, Inc. Reversible gelation compositions and methods of use
US5077033A (en) * 1990-08-07 1991-12-31 Mediventures Inc. Ophthalmic drug delivery with thermo-irreversible gels of polxoxyalkylene polymer and ionic polysaccharide
MX9200339A (es) * 1991-01-28 1992-08-01 Hoechst Ag Preparado para la liberacion controlada de sustancias activas, que son apropiadas como terapeuticos o para mejorar el crecimiento y el aprovechamiento de los piensos en rumiantes
AU679937B2 (en) * 1992-11-18 1997-07-17 Johnson & Johnson Consumer Products, Inc. Extrudable compositions for topical or transdermal drug delivery

Also Published As

Publication number Publication date
WO1994023750A1 (en) 1994-10-27
RU2108112C1 (ru) 1998-04-10
EP0694310A1 (en) 1996-01-31
DE69327878T2 (de) 2000-06-15
FI953575A0 (sv) 1995-07-26
CN1048393C (zh) 2000-01-19
ATE189772T1 (de) 2000-03-15
KR0162025B1 (ko) 1998-12-01
EP0694310B1 (en) 2000-02-16
IL107626A0 (en) 1994-02-27
CA2153234C (en) 1999-02-16
FI112778B (sv) 2004-01-15
KR960700075A (ko) 1996-01-19
DK0694310T3 (da) 2000-06-05
DE69327878D1 (de) 2000-03-23
AU5433394A (en) 1994-11-08
HUT71676A (en) 1996-01-29
HU220864B1 (en) 2002-06-29
AU668447B2 (en) 1996-05-02
HU9502086D0 (en) 1995-09-28
HK1017805A1 (en) 1999-11-26
NO311635B1 (no) 2001-12-27
NO953189L (no) 1995-08-14
CA2153234A1 (en) 1994-10-27
IL107626A (en) 1997-09-30
EP0694310A4 (en) 1996-04-24
NO953189D0 (no) 1995-08-14
US5624962A (en) 1997-04-29
CN1097593A (zh) 1995-01-25
ES2141775T3 (es) 2000-04-01

Similar Documents

Publication Publication Date Title
FI953575A (sv) Vattenhaltig medicinsk sammansättning, som har reversibel varmhärdande stelningsegenskap
BR9306841A (pt) Composição farmacêutica processo para proporcionar um tratamento anti-histamínico o qual não induz qualquer arritmia cardíaca significativa em um paciente ser humano e uso de uma composição para a mnaufactura de um medicamento para uso em um tratamento anti-histamínico
CY1109869T1 (el) Παραγωγη πεπτιδιων και φαρμακευτικα αποδεκτων αλατων τους, τροποι συνθεσης, χρησης και φαρμακευτικης συνθεσης
DE69327432D1 (de) Heilmittel für wunden und hämorrhoiden
BR0306513A (pt) tampão com medicamento
BR9916694A (pt) Composição de lenço facial e método de uso parasequestração de irritantes cutâneos de secreçãonasal
ES2072447T3 (es) Locion analgesica externa y procedimiento de preparacion.
KR910005885B1 (ko) 염화리소짐 및 글리치르히진산 디칼륨 함유 수용액제제
CY1110078T1 (el) Παρασκευασματα με ιωδιουχο ποβιδονη για την αγωγη τραυματων
ES2153906T3 (es) Uso de incienso para el tratamiento de la enfermedad de alzheimer.
ATE180671T1 (de) Hydrierte rizinusöl-enthaltende injizierbare formulierungen mit verlängerter wirkstoffabgabe
US4300555A (en) Product, composition, and process for anorectal prophylactic and/or therapeutic care
DE60018409D1 (de) Verwendung von antiseptika zur herstelllung von arzneimitteln zur prophylaxe und behandlung von infektionen und/ oder funktionellen gewebeumformungen im körperinneren
KR970032872A (ko) 아세틸살리실산을 함유하는 피부 손상 처치용 약물
KR930019224A (ko) 유산 위험 치료제
ES2182840T3 (es) Factor xiii para el tratamiento de heridas de la piel.
KR920703060A (ko) 제약학적 배합물
ATE173405T1 (de) Arzneimittel auf basis von hyaluronsäure
DE69228686D1 (de) Topisch anzuwendendes arzneimittel enthaltend penciclovir
ATE203903T1 (de) Delta-aminolävulinsäure enthaltendes arzneimittel
HU911272D0 (en) Process for the production of medical preparations containing hexetidine
KR927003530A (ko) 이온삼투요법용 제약 제제의 제조에 있어서의 국소 마취제의 용도
BR0205625C1 (pt) Formulações nasais em gel
ATE87465T1 (de) Neues arzneimittel mit antiallergischer wirkung und verzoegerter wirkstofffreigabe.
HU209063B (en) Composition disinfecting and indicating body paris

Legal Events

Date Code Title Description
MM Patent lapsed